ex vivo expanded haploidentical natural killer cells

· Belarusian Research Center for Pediatric Oncology, Hematology and Immunology

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ex vivo expanded haploidentical natural killer cells, covering 2024-08-28 to 2024-08-28. Get the full timeline:

Most recent: Clinical Trial Update: Immunotherapy With ex Vivo Expanded Haploidentical Natural Killer Cells for Children/Young Adults With AML [Phase 1, Phase 2]

See pricing